Shorts

1:16
Impact of Speech and Physical Therapy in Parkinson Disease
a year ago
by
Cynthia Fox, PhD, CCC-SLP(+1 more)

1:33
Biomarkers to Guide Remyelination Strategies in MS
a year ago
by
Ahmed Abdelhak, MD(+1 more)

1:07
Early Identification of Atypical Parkinsonian Syndromes
a year ago
by
David Shprecher, DO, MSci, FAAN(+1 more)

1:28
Subjective Cognitive Complaints During the Interictal Period in Migraine
a year ago
by
Laura Sebrow, PhD(+1 more)

1:10
Consensus Definitions for Refractory and Resistant Migraine
a year ago
by
Jennifer Robblee, MD(+1 more)

1:10
The Future of Migraine Treatment
a year ago
by
Patricia Pozo-Rosich, MD, PhD(+1 more)

1:10
Understanding Adolescent Migraine Suffering
a year ago
by
Patricia Pozo-Rosich, MD, PhD(+1 more)

0:30
Overviewing New Gene Therapy Guidelines w/ Dr. Byrne
a year ago
by
Marco Meglio(+1 more)

1:00
Multidisciplinary Care for Gene Therapy Use in DMD
a year ago
by
Marco Meglio(+1 more)
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3 NIMBLE Trial: Cemdisiran Efficacy and Safety Results in gMG
2
Myelin Repair Research in MS: Lessons From Clinical Trials and the Road Ahead
3
From Glucose to Cognition: Where Repurposed Diabetes Drugs Stand in Alzheimer Disease
4
FDA Requires NAION Warning Across GLP-1 Receptor Agonist Class
5
